Neuraxis Share Price Today
(NASDAQ: NRXS)

Name: Neuraxis Share Price Today (NASDAQ: NRXS) - Neuraxis Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Neuraxis share price is $2.14 & ₹186.11 as on 6 Mar 2025, 2.30 'hrs' IST

$2.14

▲

-0.04

(-1.83%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Neuraxis share price in Dollar and Rupees. Guide to invest in Neuraxis stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Neuraxis, along with analyst recommendations, forecasts, and comprehensive financials.

Neuraxis share price movements

Today's Low: $2.14
Today's High: $2.24
$2.14
0.0%
Downside
Day's Volatility :4.46%
Upside
4.46%
52 Weeks Low: $2.05
52 Weeks High: $3.78
$2.14
4.21%
Downside
52 Weeks Volatility :45.77%
Upside
43.39%

Neuraxis (NRXS) Returns

Period	Neuraxis Inc	Index (Russel 2000)
3 Months	-18.05%	0.0%
6 Months	-27.81%	0.0%
1 Year	-38.94%	0.0%
3 Years	-63.67%	-11.6%

Neuraxis (NRXS) Key Statistics

in dollars & INR

Previous Close	$2.18
Open	$2.2
Today's High	$2.24
Today's Low	$2.14
Market Capitalization	$15.2M
Today's Volume	$730.0
52 Week High	$3.78
52 Week Low	$2.05
Revenue TTM	$2.5M
EBITDA	$-7.3M
Earnings Per Share (EPS)	$-0.4
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

How to invest in Neuraxis Stock (NRXS) from India?

It is very easy for Indian residents to invest directly in Neuraxis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Neuraxis stock in both Indian Rupees (INR) and US Dollars (USD). Search for Neuraxis or NRXS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Neuraxis or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Neuraxis shares which would translate to 0.406 fractional shares of Neuraxis as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Neuraxis, in just a few clicks!

Returns in Neuraxis (NRXS) for Indian investors in Rupees

The Neuraxis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Neuraxis investment value today

Current value as on today

₹64,907

Returns

₹35,093

(-35.09%)

Returns from Neuraxis Stock

₹40,056 (-40.06%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Neuraxis (NRXS)

-13%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Neuraxis Stock from India on INDmoney has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Neuraxis

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Neuraxis(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Neuraxis Stock (NRXS)

What analysts predicted

Upside of 250.47%

Target:

$7.50

Current:

$2.14

Insights on Neuraxis Stock (Ticker Symbol: NRXS)

Price Movement
In the last 7 days, NRXS stock has moved up by 1.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 611.5K → 666.62K (in $), with an average increase of 8.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -2.91M → -1.75M (in $), with an average increase of 66.2% per quarter
NRXS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 102.6%
Price to Sales
ForNRXS every $1 of sales, investors are willing to pay $5.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

NRXS Neuraxis Financials in INR & Dollars

	FY20	Y/Y Change
Revenue	$1.9M	-
Net Income	$-4.1M	-
Net Profit Margin	-209.83%	-

	FY21	Y/Y Change
Revenue	$2.7M	↑ 40.98%
Net Income	$-3.1M	↓ 24.12%
Net Profit Margin	-112.93%	↑ 96.9%

	FY22	Y/Y Change
Revenue	$2.7M	↓ 1.34%
Net Income	$-4.8M	↑ 55.54%
Net Profit Margin	-178.05%	↓ 65.12%

	FY23	Y/Y Change
Revenue	$2.5M	↓ 8.37%
Net Income	$-14.6M	↑ 205.99%
Net Profit Margin	-594.57%	↓ 416.52%

	Q2 FY23	Q/Q Change
Revenue	$646.0K	↓ 19.76%
Net Income	$-2.2M	↑ 2.86%
Net Profit Margin	-346.06%	↓ 76.11%

	Q3 FY23	Q/Q Change
Revenue	$477.5K	↓ 26.09%
Net Income	$-4.9M	↑ 119.37%
Net Profit Margin	-1.0K%	↓ 681.12%

	Q4 FY23	Q/Q Change
Revenue	$531.5K	↑ 11.31%
Net Income	$-5.3M	↑ 8.34%
Net Profit Margin	-999.76%	↑ 27.42%

	Q1 FY24	Q/Q Change
Revenue	$646.6K	↑ 21.67%
Net Income	$-2.1M	↓ 60.09%
Net Profit Margin	-327.95%	↑ 671.81%

	Q2 FY24	Q/Q Change
Revenue	$611.5K	↓ 5.43%
Net Income	$-2.9M	↑ 37.59%
Net Profit Margin	-477.14%	↓ 149.19%

	Q3 FY24	Q/Q Change
Revenue	$666.6K	↑ 9.01%
Net Income	$-1.8M	↓ 39.84%
Net Profit Margin	-263.3%	↑ 213.84%

	FY20	Y/Y Change
Profit	$1.4M	-

	FY21	Y/Y Change
Profit	$2.3M	↑ 55.52%

	FY22	Y/Y Change
Profit	$2.4M	↑ 5.95%

	FY23	Y/Y Change
Profit	$2.2M	↓ 9.67%

	Q2 FY23	Q/Q Change
Profit	$578.2K	↓ 18.47%

	Q3 FY23	Q/Q Change
Profit	$410.2K	↓ 29.06%

	Q4 FY23	Q/Q Change
Profit	$459.1K	↑ 11.93%

	Q1 FY24	Q/Q Change
Profit	$571.6K	↑ 24.49%

	Q2 FY24	Q/Q Change
Profit	$538.0K	↓ 5.86%

	Q3 FY24	Q/Q Change
Profit	$569.6K	↑ 5.86%

	FY20	Y/Y Change
Operating Cash Flow	$-4.1M	-
Investing Cash Flow	$-27.7K	-
Financing Cash Flow	$6.1M	-

	FY21	Y/Y Change
Operating Cash Flow	$-2.2M	↓ 46.02%
Investing Cash Flow	$-1.4K	↓ 94.99%
Financing Cash Flow	$661.1K	↓ 89.08%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-625.2K	↑ 0.37%
Investing Cash Flow	$-5.5K	↓ 28.25%
Financing Cash Flow	$636.7K	↑ 50.77%

Neuraxis Technicals Summary

Sell

Neutral

Buy

Neuraxis is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Neuraxis (NRXS) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Neuraxis Inc	-16.01%	-27.81%	-38.94%	-63.67%	-63.67%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Neuraxis Inc	NA	NA	NA	0.0	0.0	-3.84	NA	-0.26
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Neuraxis Inc	Buy	$15.2M	-63.67%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Neuraxis

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Organization	Neuraxis
Employees	19
CEO	Mr. Brian Carrico
Industry	Miscellaneous

Management People of Neuraxis

Name	Title
Mr. Brian Carrico	President, CEO & Director
Mr. Timothy Robert Henrichs	Chief Financial Officer
Dr. Adrian Miranda	Senior VP of Science & Technology and Chief Medical Officer
Dr. Thomas Carrico	Chief Regulatory Officer and Compliance & Privacy Officer
Dr. Christopher Robin Brown D.D.S.	Founder, Director of Innovation & Director

Important FAQs about investing in NRXS Stock from India :

What is Neuraxis share price today?

Neuraxis share price today stands at $2.14, Open: $2.20 ; Previous Close: $2.18 ; High: $2.24 ; Low: $2.14 ; 52 Week High: $3.78 ; 52 Week Low: $2.05.

The stock opens at $2.20, after a previous close of $2.18. The stock reached a daily high of $2.24 and a low of $2.14, with a 52-week high of $3.78 and a 52-week low of $2.05.

Can Indians buy Neuraxis shares?

Yes, Indians can invest in the Neuraxis (NRXS) from India.

With INDmoney, you can buy Neuraxis at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Neuraxis at zero transaction cost.

How can I buy Neuraxis shares from India?

It is very easy to buy Neuraxis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Neuraxis (NRXS) be purchased?

Yes, you can buy fractional shares of Neuraxis with INDmoney app.

What are the documents required to start investing in Neuraxis stocks?

To start investing in Neuraxis, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.